Home » Newsletters » BioWorld

BioWorld

April 13, 1995

View Archived Issues

ROCHE STARTS PHASE III FOR PDL'S ANTI-TAC ANTIBODY

ORAVAX, PASTEUR MERIEUX ESTABLISH JOINT VENTURE

GENENTECH FIRST QUARTER EARNINGS BETTER THAN EXPECTED

CELTRIX CONTINUES RESTRUCTURING IN WAKE OF BETAKINE DISAPPOINTMENTS

HYBRIDON RAISES $26.5M IN PRIVATE PLACEMENT, REACHES MILESTONE WITH

FINDING AMYLOID PLAQUES IS ONE THING; HOW THEY KILL NEURONS IS ANOTHER